CCN2 and diabetic kidney disease: CTGF has been reported to be involved in various chronic diseases including systemic sclerosis, lung fibrosis, cardiac fibrosis, atherosclerosis, liver fibrosis, kidney fibrosis, diabetic nephropathy (DN), and peritoneal fibrosis in peritoneal dialysis patients [1,2].